Upcoming Study

Cutaneous Lupus Erythematosus Research Study

Discover how clinical trials are opening new possibilities for people living with lupus rashes, sun-triggered flares and stubborn skin symptoms.

Cutaneous Lupus Erythematosus Research Study
doctor examining a lupus patient’s shoulder.

Calmer Skin, Fewer Flares: A Study for People With Cutaneous Lupus

Lupus doesn’t always stay inside the body. For many people, it shows up on the skin as red, scaly patches, scarring sores or rashes that flare in the sun. These symptoms can be painful, hard to hide and tough on confidence, even when you’re following your doctor’s plan.

 

This Cutaneous Lupus Erythematosus Research Study is a Phase 3 clinical trial testing an investigational study drug in adults with active skin lupus, with or without systemic lupus. Participants take the study tablet for 24 weeks, and some may receive a placebo. Studies like this help doctors learn what calms skin disease, and joining could help move lupus care forward for the next person. Enrolment will open soon, stay tuned.

Condition

Cutaneous Lupus Erythematosus (with or without Systemic Lupus Erythematosus)

Gender

Both

Age

18 to 75 Years

Status

Upcoming

Location

Richardson, Texas

Number of Studies

01

Frequently Asked Questions

Cutaneous lupus erythematosus is a form of lupus that mainly affects the skin. It can cause red or scaly patches, scarring lesions and rashes that often get worse in the sun. Some people have skin lupus on its own, while others also have systemic lupus, which can affect the joints and organs.

Yes. We’re preparing to open an upcoming study here in Richardson for adults with active cutaneous lupus. Contact our team to ask about eligibility and get updates as enrollment gets closer.

After a screening visit to confirm you qualify, you’ll take the study tablet for 24 weeks and come in about every four weeks. Your study team will walk you through every step, and you can ask questions or step away at any time.